Glutathione-related redox imbalance and cognitive impairment in drug-naïve, first-episode schizophrenia: a focus on GSSG
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Cognitive impairment is a core feature of schizophrenia, yet the biological basis has not been established. Redox dysregulation has been implicated in cognitive impairment of patients with schizophrenia but evidence in early-stage, drug-naïve patients is limited and inconsistent. Herein we examined glutathione-related redox markers and the associations with cognition in 96 drug-naïve, first-episode schizophrenia patients and 94 matched controls. Patients with schizophrenia exhibited a systemic redox imbalance that was characterized by increased glutathione (GSH) and glutathione disulfide (GSSG) levels with a reduced GSH-to-GSSG ratio, while glutathione reductase activity remained unchanged. Marked cognitive deficits were observed across all domains. Among redox markers, GSSG showed robust and consistent negative associations with global cognition and multiple domains, and emerged as an independent predictor after covariate adjustment. In contrast, GSH and the GSH-to-GSSG ratio had weaker and less stable associations. No reliable relationships were demonstrated between redox markers and clinical symptoms after correction for multiple comparisons. These findings are the basis for a functionally asymmetric redox dysregulation model, in which increased oxidative load, indexed by GSSG, has a central role in early cognitive impairment, relatively independent of antioxidant capacity. These findings highlight GSSG as a candidate biomarker for early cognitive impairment and suggest redox-targeted interventions as a potential therapeutic strategy in schizophrenia.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Glutathione-related redox imbalance and cognitive impairment in drug-naïve, first-episode schizophrenia: a focus on GSSG
- Date Crossref
- 09/07/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Nantong University pays non établi dans la noticeUniversité ou école supérieure
-
Affiliated Hospital of Nantong University pays non établi dans la noticeÉtablissement de santé
-
Second People's Hospital of NanTong pays non établi dans la noticeÉtablissement de santé
-
Soochow University pays non établi dans la noticeUniversité ou école supérieure
-
Suzhou Guangji Hospital pays non établi dans la noticeÉtablissement de santé
-
Second Affiliated Hospital of Soochow University pays non établi dans la noticeÉtablissement de santé
-
First Affiliated Hospital of Soochow University pays non établi dans la noticeÉtablissement de santé
-
Nantong Mental Health Center Department of Psychiatry pays non établi dans la noticeÉtablissement de santé
Nantong University, Affiliated Hospital of Nantong University et Second People's Hospital of NanTong, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.